The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Recurrent Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: NKTR-102|DRUG: Treatment of Physician's Choice (TPC)
Sponsor: Nektar Therapeutics